Skip to main content
Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.210
+0.050 (1.20%)
At close: Nov 13, 2026, 4:00 PM EST
4.161
-0.050 (-1.18%)
After-hours: Nov 13, 2026, 7:30 PM EST

Relmada Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
44935416125105625
Market Cap Growth
311.34%2157.41%-87.41%18.63%-83.18%19.93%
Enterprise Value
247340-3818-79537
Last Close Price
4.214.830.524.143.4922.53

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.324.090.441.460.753.00
P/TBV Ratio
2.324.090.441.460.753.00

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.04-1.07-1.26-1.13-1.06-1.02
Net Debt / EBITDA Ratio
----0.921.69
Net Debt / FCF Ratio
3.902.030.871.871.432.31
Quick Ratio
26.0014.464.367.9011.9414.08
Current Ratio
26.3714.624.458.0012.2614.83
Return on Equity (ROE)
-64.66%-94.05%-132.33%-87.51%-90.07%-80.14%
Return on Assets (ROA)
-36.90%-50.24%-73.14%-51.76%-53.57%-46.01%
Return on Capital Employed (ROCE)
-32.90%-64.20%-236.10%-121.50%-114.80%-60.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.76%-16.20%-509.73%-79.28%-149.50%-20.13%
FCF Yield
-11.54%-12.93%-329.85%-41.46%-98.81%-14.71%
Buyback Yield / Dilution
-193.18%-30.89%-0.21%-1.59%-68.80%-12.56%
SEC Filings: 10-K · 10-Q